Target Price | GBP15.81 |
Price | GBP14.76 |
Potential |
7.11%
register free of charge
|
Number of Estimates | 25 |
25 Analysts have issued a price target GlaxoSmithKline 2026 .
The average GlaxoSmithKline target price is GBP15.81.
This is
7.11%
register free of charge
GBP26.46
79.27%
register free of charge
GBP11.31
23.36%
register free of charge
|
|
A rating was issued by 31 analysts: 12 Analysts recommend GlaxoSmithKline to buy, 15 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the GlaxoSmithKline stock has an average upside potential 2026 of
7.11%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion GBP | 31.38 | 33.15 |
3.46% | 5.66% | |
EBITDA Margin | 26.11% | 33.95% |
5.46% | 30.03% | |
Net Margin | 8.21% | 20.88% |
49.49% | 154.42% |
25 Analysts have issued a sales forecast GlaxoSmithKline 2025 . The average GlaxoSmithKline sales estimate is
This results in the following potential growth metrics:
21 Analysts have issued an GlaxoSmithKline EBITDA forecast 2025. The average GlaxoSmithKline EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
24 GlaxoSmithKline Analysts have issued a net profit forecast 2025. The average GlaxoSmithKline net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share GBP | 0.62 | 1.67 |
48.33% | 169.35% | |
P/E | 8.79 | |
EV/Sales | 2.20 |
24 Analysts have issued a GlaxoSmithKline forecast for earnings per share. The average GlaxoSmithKline EPS is
This results in the following potential growth metrics and future valuations:
GlaxoSmithKline...
Analyst | Rating | Action | Date |
---|---|---|---|
Shore Capital |
Locked
➜
Locked
|
Locked | Aug 27 2025 |
JP Morgan Cazenove |
Locked
➜
Locked
|
Locked | Aug 04 2025 |
Deutsche |
Locked
➜
Locked
|
Locked | Jul 31 2025 |
Shore Capital |
Locked
➜
Locked
|
Locked | Jul 30 2025 |
Deutsche |
Locked
➜
Locked
|
Locked | Jul 21 2025 |
JP Morgan Cazenove |
Locked
➜
Locked
|
Locked | Jul 18 2025 |
Shore Capital |
Locked
➜
Locked
|
Locked | Jul 18 2025 |
Analyst Rating | Date |
---|---|
Locked
Shore Capital:
Locked
➜
Locked
|
Aug 27 2025 |
Locked
JP Morgan Cazenove:
Locked
➜
Locked
|
Aug 04 2025 |
Locked
Deutsche:
Locked
➜
Locked
|
Jul 31 2025 |
Locked
Shore Capital:
Locked
➜
Locked
|
Jul 30 2025 |
Locked
Deutsche:
Locked
➜
Locked
|
Jul 21 2025 |
Locked
JP Morgan Cazenove:
Locked
➜
Locked
|
Jul 18 2025 |
Locked
Shore Capital:
Locked
➜
Locked
|
Jul 18 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.